相关实验视频
Updated: Jun 15, 2025
06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
6.6K
抗抑郁药在功能性消化不良症中的有效性:随机对照试验的试验顺序分析的系统综述和元分析
Suresh Shanmugham1, Mohammed Zuber2, Jia En Chan1
1Department of Pharmacy Practice, School of Pharmacy, IMU University, 57000, Kuala Lumpur, Malaysia.
概括
三环抗抑郁药 (TCA) 显示了改善功能性消化不良 (FD) 症状的确证据,需要治疗的数量很低. 然而,益处仅限于西方人群,对亚洲人群需要更多的研究.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 之前的元分析表明抗抑郁药可能有利于功能性消化不良 (FD) 症状,但结果仍然没有确定性.
- 进行了更新的元分析和试验序列分析 (TSA),以澄清成人FD治疗中的抗抑郁药物的疗效.
研究的目的:
- 评估抗抑郁药在治疗成人功能性消化不良 (FD) 的疗效.
- 通过试验顺序分析 (TSA) 和GRADE方法提供确的证据.
主要方法:
- 系统搜索成年FD患者的随机对照试验 (RCT) 到2024年3月.
- 综合风险比率 (RR) 症状改善使用随机效应模型和TSA.
- 使用推评估,开发和评价 (GRADE) 方法评估证据确定性.
主要成果:
- 分析了9个RCT (924名患者). 三环抗抑郁药 (TCA) 显示出显著的益处 (RR=1.41),治疗所需数 (NNT) 为6.
- 交通安全局证实了TCA的确证据,并提供了中等等级质量的证据.
- 在西方人群中观察到好处,但不是亚洲人群. 总体而言,不良事件的发生频率更高,但与TCA没有显著联系.
结论:
- TCA代表了功能性消化不良 (FD) 的潜在有效治疗选择.
- 需要进一步进行高质量的试验来确认有效性,特别是在亚洲人群中.
- 这项研究强调了在对FD的抗抑郁药治疗中需要人口特异性证据的需要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
337
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
337
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
228
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
228
01:25Antidepressant Drugs: Overview
394
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
394
01:17Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
410
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
410